CSI Market
Sign In | Register

Chemed (CHE) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access CHE Annual Cash Flow →
Cash flow data covering Chemed–Jun 30 2025 offers a view into how Jun 30 2026's cash position has developed alongside business activity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income134.01
Depreciation & amortization33.86
Amortization of Other Assets5.29
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Impairment of Long-Lived Assets to be Disposed of0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.09
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation23.25
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Depreciation Amortization Of Intangibles And Stock Award-
Litigation Settlement Expense-
Amortization Of Restricted Stock Awards-
Loss On Sale Of Transportation Equipment-
Ununtilized Cares Act Grant Operating Activity-
Deferred Payroll Taxes-
Pension And Other Postretirement Benefits Expense Reversal Of Expense Noncash1.39
Increase Decrease In Lease Assets And Liabilities-0.47
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable6.72
Increase (Decrease) in Accounts Payable9.17
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense10.29
Other Working Capital20.68
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-70.31
Discontinued operations0.00
Net Cash flow from Operating Activities173.03
Investing Activities
Capital Expenditures-32.64
Sale of Capital Items0.42
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired-33.54
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities-0.27
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-66.03
Financing Activities
Short-term debt Net23.31
Other borrowing transactions-1.35
Long-term debt - borrowings491.48
Long-term debt - repayments-351.48
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock-284.79
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net-2.42
Other net0.00
Net Increase Decrease Of Revolving Line Of Credit-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid-16.05
Net Cash Flow from Financing Activities-141.30
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow140.82
Total Cash Flow-34.29
4 historic quarters locked

Sign in to unlock the full Chemed cash flow history.

Sign In Create Free Account

About Chemed Corp Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0000019584-26-000020

Figures are derived from filed reports and may be restated. Historical data is subject to revision.